The purpose of this study is to demonstrate the non-inferiority of meropenem (Merrem) and imipenem in hospitalised subjects with complicated skin and skin structure infections.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
1,000
Intravenous
Intravenous
The primary measure is clinical response after all antibacterial treatment is stopped).
Time frame: 7-28 days
clinical and microbiological response
Time frame: Twice 3-28 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.